Загрузка...
Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study
The present retrospective, single-center study evaluated the objective response rate (ORR) and progression-free survival (PFS) of epidermal growth factor receptor (EGFR) mutation-positive Malaysian patients with advanced lung adenocarcinoma treated with gefitinib. During May 2008 to July 2013, 33 pa...
Сохранить в:
| Опубликовано в: : | Oncol Lett |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4812101/ https://ncbi.nlm.nih.gov/pubmed/27073548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4322 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|